INHIBIKASE THERAPEUTICS INC (IKT)

US45719W2052 - Common Stock

2.01  +0.03 (+1.52%)

After market: 2 -0.01 (-0.5%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.